FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to clinical immunology. Disclosed is a method of determining the phagocytic activity of neutrophils, in which the initial concentration of the solution of Saccharomyces cerevisiae is 0.00125 %; for experimental and control groups initial concentration of mononuclear cells - 2⋅106 cells/ml; for the test and control groups in a round-bottom polystyrene plate or in eppendorf tubes, mixture of 100 mcl of Saccharomyces cerevisiae solution and 100 mcl of mononuclear solution is made; plate or test tubes are incubated with anaerobic culture apparatus content at temperature of 36 ± 1 °C for 60 minutes; in 60 minutes from each well of the plate or from each test tube, contents of 100 mcl are inoculated into separate Petri dishes, followed by incubation in anaerobic culture apparatus at 26 ± 2 °C for 18 hours; after 18 hours in each Petri dish, Saccharomyces cerevisiae colonies are counted and the NPA is compared in the test and control groups, wherein the immunosuppression state reduces the functional activity of the neutrophils, which is manifested in the form of a greater number of grown colonies of Saccharomyces cerevisiae in the test group compared to the control, and in the immunostimulation state, a decrease in the number of the grown Saccharomyces cerevisiae colonies in the test group as compared to the control is observed.
EFFECT: invention provides a wider range of methods for assessing nonspecific immunity.
1 cl, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR CALCULATING DOSE OF DEXAMETHAZONE FOR DEVELOPMENT OF BIOLOGICAL MODEL OF IMMUNOSUPPRESSION IN MICE | 2020 |
|
RU2748123C1 |
METHOD FOR STUDYING PHAGOCYTOSIS IN THE WHOLE BLOOD | 1992 |
|
RU2054172C1 |
METHOD FOR DETERMINING NONSPECIFIC RESISTANCE OF ANIMAL ORGANISM | 1992 |
|
RU2038820C1 |
METHOD FOR PRODUCING BIOLOGICALLY ACTIVE COMPONENTS FROM YEAST CELLS SACCHAROMYCES CEREVISIAE AND A THERAPEUTIC AGENT BASED THEREON | 2018 |
|
RU2722731C2 |
METHOD OF DETERMINING MUTAGENIC ACTIVITY OF CHEMICALS | 2022 |
|
RU2810923C1 |
METHOD FOR EVALUATING TOTAL SECRETORY MACROPHAGUE ACTIVITY OF VARIOUS COMPARTMENTS IN CONTINUOUS CULTIVATION | 2011 |
|
RU2460783C1 |
MEDICATION POSSESSING IMMUNOSTIMULATING AND HEMOSTIMULATING ACTION | 2009 |
|
RU2414223C1 |
ANTIBACTERIAL COMPOSITION BASED ON ENDOLYSINS AND DRUGS IN FORM OF GEL OR SPRAY, USING IT | 2021 |
|
RU2790481C1 |
METHOD FOR ASSESSING NEUTROPHILOCYTOPOIESIS ON CELL REACTIVITY ON NEUTROPHILOKINES | 2011 |
|
RU2473903C1 |
METHOD OF PREDICTING DEVELOPMENT OF LUNG ABSCESS IN CASE OF CHRONIC OBSTRUCTIVE LUNG DISEASE | 2009 |
|
RU2407010C1 |
Authors
Dates
2020-07-24—Published
2019-09-30—Filed